These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22464954)

  • 41. Leptin in human physiology and therapeutics.
    Dardeno TA; Chou SH; Moon HS; Chamberland JP; Fiorenza CG; Mantzoros CS
    Front Neuroendocrinol; 2010 Jul; 31(3):377-93. PubMed ID: 20600241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Leptin in humans: lessons from translational research.
    Blüher S; Mantzoros CS
    Am J Clin Nutr; 2009 Mar; 89(3):991S-997S. PubMed ID: 19176740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel approaches to the treatment of obesity and type 2 diabetes mellitus: bioactive leptin-related synthetic peptide analogs.
    Grasso P
    Recent Pat Endocr Metab Immune Drug Discov; 2011 Sep; 5(3):163-75. PubMed ID: 21913885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Effects of Leptin Replacement on Neural Plasticity.
    Paz-Filho GJ
    Neural Plast; 2016; 2016():8528934. PubMed ID: 26881138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Leptin revisited: its mechanism of action and potential for treating diabetes.
    Coppari R; Bjørbæk C
    Nat Rev Drug Discov; 2012 Sep; 11(9):692-708. PubMed ID: 22935803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CSF leptin levels after exogenous administration of recombinant methionyl human leptin.
    Fujioka K; Patane J; Lubina J; Lau D
    JAMA; 1999 Oct; 282(16):1517-8. PubMed ID: 10546689
    [No Abstract]   [Full Text] [Related]  

  • 47. New pharmacological perspectives for the leptin receptor in the treatment of obesity.
    Roujeau C; Jockers R; Dam J
    Front Endocrinol (Lausanne); 2014; 5():167. PubMed ID: 25352831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of leptin replacement on risk factors for cardiovascular disease in genetically leptin-deficient subjects.
    Paz-Filho GJ; Andrews D; Esposito K; Erol HK; Delibasi T; Wong ML; Licinio J
    Horm Metab Res; 2009 Feb; 41(2):164-7. PubMed ID: 18726825
    [No Abstract]   [Full Text] [Related]  

  • 49. Obesity research. Leptin not impressive in clinical trial.
    Gura T
    Science; 1999 Oct; 286(5441):881-2. PubMed ID: 10577231
    [No Abstract]   [Full Text] [Related]  

  • 50. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism.
    Park HK; Ahima RS
    Metabolism; 2015 Jan; 64(1):24-34. PubMed ID: 25199978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms of thrombosis in obesity.
    Blokhin IO; Lentz SR
    Curr Opin Hematol; 2013 Sep; 20(5):437-44. PubMed ID: 23817170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of leptin in the control of insulin-glucose axis.
    Amitani M; Asakawa A; Amitani H; Inui A
    Front Neurosci; 2013; 7():51. PubMed ID: 23579596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity.
    Chan JL; Wong SL; Mantzoros CS
    Clin Pharmacokinet; 2008; 47(11):753-64. PubMed ID: 18840030
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypothalamic melanocortin signaling and leptin resistance--perspective of therapeutic application for obesity-diabetes syndrome.
    Masuzaki H; Tanaka T; Ebihara K; Hosoda K; Nakao K
    Peptides; 2009 Jul; 30(7):1383-6. PubMed ID: 19394382
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic use of recombinant methionyl human leptin.
    Vatier C; Gautier JF; Vigouroux C
    Biochimie; 2012 Oct; 94(10):2116-25. PubMed ID: 22464954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
    Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients.
    Musso C; Cochran E; Javor E; Young J; Depaoli AM; Gorden P
    Metabolism; 2005 Feb; 54(2):255-63. PubMed ID: 15690321
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.